Skip to main content
CELZ
NASDAQ Life Sciences

CELZ Q3 Loss Widens to $5.58M as Cash Slips to $6.85M; 8.48M Warrants Overhang 7.60M Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.622
Mkt Cap
$4.101M
52W Low
$0.59
52W High
$4.72
52W Position info
5.4% above low
Off High info
87% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

CELZ is trading near its 52-week low of $0.59 (5.4% above the low) on light trading volume (0.1× avg).

Summary

CELZ posted a $5.58M nine-month net loss and ended September with $6.85M in cash, down from $7.21M at year-end, with warrant exercises supplying the only meaningful inflow. Warrants for 8.48M shares remain outstanding against 7.60M shares.


Key Events · Earnings and Guidance · CELZ

  • Nine-Month Loss Reaches $5.58M

    Net loss attributable to CMTH was $5,587,129 for the nine months ended September 30, 2026, versus $4,107,334 a year earlier. The third quarter alone lost $2,670,076.

  • Cash Down to $6.85M

    Cash fell to $6,845,741 from $7,208,126 at December 31, 2025. Operating activities used $4,459,905 over the nine months, offset by $4,057,380 of stock and warrant proceeds.

  • Warrant Overhang Exceeds Share Count

    Warrants for 8,477,684 shares were outstanding at September 30, 2026 at a $2.65 weighted-average exercise price, against 7,597,557 shares outstanding. The June 2026 inducement added 5,580,680 warrants at $1.60.

  • R&D Inflated by Non-Cash Stock Expense

    Research and development rose 52% to $2,602,546 for the nine months, including $1,166,515 of stock-based expense tied to the BioDefense investment — an accounting charge, not cash spent.


Analysis · CELZ · Life Sciences

The balance sheet, not the loss, is the story here. Cash fell to $6,845,741 from $7,208,126 at year-end, and the nine-month operating burn of $4,459,905 was covered only by $4,057,380 of warrant-exercise proceeds. Strip out that financing and the company is consuming roughly $0.5M a month. Against 7,597,557 shares outstanding sit warrants for 8,477,684 shares at a $2.65 weighted-average strike — more potential shares than exist today, though at a strike far above the current price. The quarter also carried $1,166,515 of non-cash stock expense tied to the BioDefense stake, which inflates the R&D line without touching cash. Separately, the CEO bought the company's 80% Bionance interest for $44,000 on October 23, 2026, unwinding a related-party investment at a fraction of the $125,000 originally contributed.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CELZ was trading at $0.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $0.59 to $4.72. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CELZ - Latest Insights

CELZ
Nov 13, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5281
Real-time Price: $0.4014 info
Change: -$0.1267 (-24%) info
Market Cap: $3.058M info
CELZ
Sep 25, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.4014 info
Change: -$0.5986 (-60%) info
Market Cap: $3.058M info
CELZ
Aug 20, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.21
Real-time Price: $0.4014 info
Change: -$0.8086 (-67%) info
Market Cap: $3.058M info
CELZ
Aug 07, 2026, 5:23 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.38
Real-time Price: $0.4014 info
Change: -$0.9786 (-71%) info
Market Cap: $3.058M info
CELZ
Aug 06, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $0.4014 info
Change: -$0.7689 (-66%) info
Market Cap: $3.058M info